Ectopic hTERT expression extends the life span of human CD4+ helper and regulatory T-cell clones and confers resistance to oxidative stress-induced apoptosis

Blood

Volumn 101, Issue 11, 2003, Pages 4512-4519

  Luiten, Rosalie M ^b   Pène, Jérôme ^b   Yssel, Hans ^b   Spits, Hergen ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CD4 ANTIGEN; PROTEIN BCL 2; RNA DIRECTED DNA POLYMERASE; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; TELOMERASE;

APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL CYCLE; CELL DEATH; CELL DIVISION; CELL GROWTH; CELL LABELING; CONTROLLED STUDY; DNA DAMAGE; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CELL AGING; CELL CLONE; CELL SURVIVAL; CYTOLOGY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION;

APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CELL AGING; CELL DIVISION; CELL SURVIVAL; CLONE CELLS; DNA DAMAGE; DNA-BINDING PROTEINS; HUMANS; LYMPHOCYTE ACTIVATION; OXIDATIVE STRESS; T-LYMPHOCYTE SUBSETS; TELOMERASE;

EID: 0038819110     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-07-2018     Document Type: Article

References (33)

1. Efiros RB, Pawelec G. Replicative senescence of T cells: does the Hayflick Limit lead to immune exhaustion? Immunol Today. 1997;18:450-454.
2. Pawelec G, Sansom D, Rehbein A, Adibzadeh M, Beckman I. Decreased proliferative capacity and increased susceptibility to activation-induced cell death in late-passage human CD4+ TCR2+ cultured T cell clones. Exp Gerontol. 1996;31:655-668.
3. Grubeck-Loebenstein B, Lechner H, Trieb K. Long-term in vitro growth of human T cell clones: can postmitotic "senescent' cell populations be defined? Int Arch Allergy Immunol. 1994;104:232-239.
4. Harley CB, Futcher AB, Grelder CW, Telomeres shorten during ageing of human fibroblasts. Nature. 1990;345:458-460.
5. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with ageing. Nature. 1990;346:866-868.
6. Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science. 1998;279:349-352.
7. Vaziri H, Benchimol S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr Biol. 1998;8:279-282.
8. Henle ES, Han Z, Tang N, Rai P, Luo Y, Linn S. Sequence-specific DNA cleavage by Fe2+-mediated fenton reactions has possible biological implications. J Biol Chem. 1999;274:962-971.
9. von Zglinicki T, Pilger R, Sitte N. Accumulation of single-strand breaks is the major cause of telomere shortening in human fibroblasts. Free Radic Biol Med. 2000;28:64-74.
10. Ren JG, Xia HL, Tian YM, Just T, Cal GP, Dai YR, Expression of telomerase inhibits hydroxyl radical-induced apoptosis in normal telomerase negative human lung fibroblasts. FEBS Lett. 2001;488:133-138.
11. Bodnar AG, Kim NW, Effros RB, Chiu CP. Mechanism of telomerase induction during T cell activation. Exp Cell Res, 1996;228:58-64.
12. Pan C, Xue BH, Ellis TM, Peace DJ, Diaz MO. Changes in telomerase activity and telomere length during human T lymphocyte senescence. Exp Cell Res. 1997;231:346-353.
13. Rufer N, Dragowska W, Thornbury G, Roosnek E, Lansdorp PM. Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry. Nat Biotechnol. 1998;16:743-747.
14. Vaziri H, Schachter F, Uchida I, et al. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet. 1993;52:661-667.
15. Burns JB, Lobo ST, Bartholomew BD. In vivo reduction of telomere length in human antigenreactive memory T cells. Eur J Immunol. 2000;30:1894-1901.
16. Son NH, Murray S, Yanovski J, Hodes RJ, Weng N. Lineage-specific telomere shortening and unaltered capacity for telomerase expression in human T and B lymphocytes with age. J Immuno. 2000;165:1191-1196.
17. Hooijberg E, Ruizendaal JJ, Snijders PJ, Kueter EW, Walboomers JM, Spits H. Immortalization of human CDS+ T cell clones by ectopic expression of telomerase reverse transcriptase. J Immunol. 2000;165:4239-4245.
18. Kinsella TM, Nolan GP. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum Gene Ther. 1996;7:1405.
19. Migliaccio M, Amacker M, Just T, et al. Ectopic human telomerase catalytic subunit expression maintains telomere length but is not sufficient for CD8+ T lymphocyte immortalization. J Immunol. 2000;165:4978-4984.
20. Hawley RG, Lieu FH, Fong AZ, Hawley TS. Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1994;1:136-138.
21. Lecart S, Boulay V, Raison-Peyron N, et al. Phenotypic characterization of human CD4+ regulatory T cells obtained from cutaneous dinitrochlorobenzene-induced delayed type hypersensitivity reactions. J Invest Dermatol. 2001;117:318-325.
22. Yssel H, Johnson KE, Schneider PV, et al. T cell activation-inducing epitopes of the house dust mite allergen Der p I: proliferation and lymphokine production patterns by Der p I-specific CD4+ T cell clones. J Immunol. 1992;148:738-745.
23. Sornasse T, Larenas PV, Davis KA, de Vries JE, Yssel H. Differentiation and stability of T helper 1 and 2 cells derived from naive human neonatal CD4+ T cells, analyzed at the single-cell level. J Exp Med. 1996;184:473-483.
24. Heemskerk MH, Hooijberg E, Ruizendaal JJ, et al. Enrichment of an antigen-specific T cell response by retrovirally transduced human dendritic cells. Cell Immunol. 1999;195:10-17.
25. Yssel H, De Vries JE, Koken M, Van Blitterswijk W, Spits H. Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones. J Immunol Methods. 1984;72:219-227.
26. Spits H, Keizer G, Borst J, Terhorst C, Hekman A, de Vries JE. Characterization of monoclonal antibodies against surface molecules associated with cytotoxic activity of natural and activated killer cells and clones CTL lines. Hybridoma. 1983;2:423-432.
27. Lyons AB, Parish CR. Determination of lymphocyte division by flow cytometry. J Immunol Methods. 1994;171:131-137.
28. Patel T, Gores GJ, Kaufmann SH. The role of proteases during apoptosis. FASEB J. 1996;10:587-597.
29. Harley CB. Telomerase is not an oncogene. Oncogene. 2002;21:494-502.
30. Yang J, Chang E, Cherry AM, et al. Human endothelial cell life extension by telomerase expression. J Biol Chem. 1999;274:26141-26148.
31. Jiang XR, Jimenez G, Chang E, et al. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Genet. 1999;21:111-114.
32. Morales CP, Holt SE, Ouellette M, et al. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase, Nat Genet. 1999;21:115-118.
33. Rufer N, Migliaccio M, Antonchuk J, Humphries RK, Roosnek E, Lansdorp PM. Transfer of the human telomerase reverse transcriptase (TERT) gene into T lymphocytes results in extension of replicative potential. Blood. 2001;98:597-603.